BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 37634830)

  • 1. Integrin-targeting disulfide-crosslinked micellar docetaxel eradicates lung and prostate cancer patient-derived xenografts.
    Ni D; Guo B; Zhong Z; Chen Y; Yang G; Yang J; Zhong Z; Meng F
    Acta Biomater; 2023 Oct; 170():228-239. PubMed ID: 37634830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RGD-directed 24 nm micellar docetaxel enables elevated tumor-liver ratio, deep tumor penetration and potent suppression of solid tumors.
    Yan W; Guo B; Wang Z; Yang J; Zhong Z; Meng F
    J Control Release; 2023 Aug; 360():304-315. PubMed ID: 37356754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facile fabrication of robust, hyaluronic acid-surfaced and disulfide-crosslinked PLGA nanoparticles for tumor-targeted and reduction-triggered release of docetaxel.
    Wang X; Cheng R; Zhong Z
    Acta Biomater; 2021 Apr; 125():280-289. PubMed ID: 33677162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted glioma chemotherapy by cyclic RGD peptide-functionalized reversibly core-crosslinked multifunctional poly(ethylene glycol)-b-poly(ε-caprolactone) micelles.
    Fang Y; Jiang Y; Zou Y; Meng F; Zhang J; Deng C; Sun H; Zhong Z
    Acta Biomater; 2017 Mar; 50():396-406. PubMed ID: 28065871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44-targeting hydrophobic phosphorylated gemcitabine prodrug nanotherapeutics augment lung cancer therapy.
    Guo B; Wei J; Wang J; Sun Y; Yuan J; Zhong Z; Meng F
    Acta Biomater; 2022 Jun; 145():200-209. PubMed ID: 35430336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing Dendron-Polymer Conjugate Based Targeted Drug Delivery Platforms with a "Mix-and-Match" Modularity.
    Bolu BS; Golba B; Boke N; Sanyal A; Sanyal R
    Bioconjug Chem; 2017 Dec; 28(12):2962-2975. PubMed ID: 29136371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α
    Zhong P; Meng H; Qiu J; Zhang J; Sun H; Cheng R; Zhong Z
    J Control Release; 2017 Aug; 259():176-186. PubMed ID: 27986551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cRGD peptide installation on cisplatin-loaded nanomedicines enhances efficacy against locally advanced head and neck squamous cell carcinoma bearing cancer stem-like cells.
    Miyano K; Cabral H; Miura Y; Matsumoto Y; Mochida Y; Kinoh H; Iwata C; Nagano O; Saya H; Nishiyama N; Kataoka K; Yamasoba T
    J Control Release; 2017 Sep; 261():275-286. PubMed ID: 28666729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic-RGDfK peptide conjugated succinoyl-TPGS nanomicelles for targeted delivery of docetaxel to integrin receptor over-expressing angiogenic tumours.
    Kulhari H; Pooja D; Shrivastava S; Telukutala SR; Barui AK; Patra CR; Naidu Vegi GM; Adams DJ; Sistla R
    Nanomedicine; 2015 Aug; 11(6):1511-20. PubMed ID: 25933692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cRGD-functionalized reduction-sensitive shell-sheddable biodegradable micelles mediate enhanced doxorubicin delivery to human glioma xenografts in vivo.
    Zhu Y; Zhang J; Meng F; Deng C; Cheng R; Feijen J; Zhong Z
    J Control Release; 2016 Jul; 233():29-38. PubMed ID: 27178807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α
    Zhong P; Gu X; Cheng R; Deng C; Meng F; Zhong Z
    Int J Nanomedicine; 2017; 12():7913-7921. PubMed ID: 29138558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-interactive mPEG-
    Gong F; Wang R; Zhu Z; Duan J; Teng X; Cui ZK
    Drug Deliv; 2020 Dec; 27(1):238-247. PubMed ID: 32003299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted chemotherapy for subcutaneous and orthotopic non-small cell lung tumors with cyclic RGD-functionalized and disulfide-crosslinked polymersomal doxorubicin.
    Zou Y; Wei J; Xia Y; Meng F; Yuan J; Zhong Z
    Signal Transduct Target Ther; 2018; 3():32. PubMed ID: 30564464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of PSMA-targeted and core-crosslinked glycol chitosan micelles for docetaxel delivery in prostate cancer therapy.
    Feng X; Zhou Y; Xie X; Li M; Huang H; Wang L; Xu X; Yu J
    Mater Sci Eng C Mater Biol Appl; 2019 Mar; 96():436-445. PubMed ID: 30606553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic RGD-Functionalized and Disulfide-Crosslinked Iodine-Rich Polymersomes as a Robust and Smart Theranostic Agent for Targeted CT Imaging and Chemotherapy of Tumor.
    Zou Y; Wei Y; Sun Y; Bao J; Yao F; Li Z; Meng F; Hu C; Storm G; Zhong Z
    Theranostics; 2019; 9(26):8061-8072. PubMed ID: 31754381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facile construction of bioreducible crosslinked polypeptide micelles for enhanced cancer combination therapy.
    Ruttala HB; Chitrapriya N; Kaliraj K; Ramasamy T; Shin WH; Jeong JH; Kim JR; Ku SK; Choi HG; Yong CS; Kim JO
    Acta Biomater; 2017 Nov; 63():135-149. PubMed ID: 28890258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cRGD peptide-installed epirubicin-loaded polymeric micelles for effective targeted therapy against brain tumors.
    Quader S; Liu X; Chen Y; Mi P; Chida T; Ishii T; Miura Y; Nishiyama N; Cabral H; Kataoka K
    J Control Release; 2017 Jul; 258():56-66. PubMed ID: 28483513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic RGD-conjugated Pluronic
    Lim C; Moon J; Sim T; Hoang NH; Won WR; Lee ES; Youn YS; Choi HG; Oh K; Oh KT
    Int J Nanomedicine; 2018; 13():4627-4639. PubMed ID: 30127610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling target engagement and cellular uptake of cRGD-decorated clinical-stage core-crosslinked polymeric micelles.
    De Lorenzi F; Rizzo LY; Daware R; Motta A; Baues M; Bartneck M; Vogt M; van Zandvoort M; Kaps L; Hu Q; Thewissen M; Casettari L; Rijcken CJF; Kiessling F; Sofias AM; Lammers T
    Drug Deliv Transl Res; 2023 May; 13(5):1195-1211. PubMed ID: 35816231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-crosslinkable and intracellularly decrosslinkable biodegradable micellar nanoparticles: A robust, simple and multifunctional nanoplatform for high-efficiency targeted cancer chemotherapy.
    Zou Y; Fang Y; Meng H; Meng F; Deng C; Zhang J; Zhong Z
    J Control Release; 2016 Dec; 244(Pt B):326-335. PubMed ID: 27245309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.